"Real world" eligibility for aducanumab

Marco Canevelli^{1

2}, Paolo Dionigi Rossi³, Paolo Astrone⁴, Ernesto Consorti⁵, Nicola Vanacore², Matteo Cesari^{6

7}

Affiliations

¹ Department of Human Neuroscience, Sapienza University, Rome, Italy.
² National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.
³ Geriatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Subacute Care Unit, Azienda Socio Sanitaria Territoriale (ASST) Lodi, Lodi, Italy.
⁵ Fellowship in Geriatrics and Gerontology, University of Milan, Italy.
⁶ Geriatric Unit, IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy.
⁷ Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Marco Canevelli et al. J Am Geriatr Soc. 2021 Oct.

. 2021 Oct;69(10):2995-2998.

doi: 10.1111/jgs.17390. Epub 2021 Jul 31.

Marco Canevelli^{1

2}, Paolo Dionigi Rossi³, Paolo Astrone⁴, Ernesto Consorti⁵, Nicola Vanacore², Matteo Cesari^{6

7}

¹ Department of Human Neuroscience, Sapienza University, Rome, Italy.
² National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.
³ Geriatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Subacute Care Unit, Azienda Socio Sanitaria Territoriale (ASST) Lodi, Lodi, Italy.
⁵ Fellowship in Geriatrics and Gerontology, University of Milan, Italy.
⁶ Geriatric Unit, IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy.
⁷ Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

No abstract available

Publication types